Changes in NO production and/or nNOS expression have been implicated in the etiopathology of various neurological or psychiatric diseases, including Parkinson’s disease, Alzheimer’s disease, major depression, and schizophrenia [18,19,20]. Here, NOS1 is linked to psychiatric disorder.